Skip to main content
Clinical Trials/NCT00000255
NCT00000255CompletedPhase 2

Differential Acute Tolerance Development to Effects of Nitrous Oxide

University of Chicago1 site in 1 country10 target enrollmentStarted: April 1995Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
10
Locations
1
Primary Endpoint
Pain intensity, pain bothersomeness

Study Overview

Brief Summary

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine differential acute tolerance development to effects of nitrous oxide in humans.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
21 Years to 37 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

30% nitrous oxide

Active Comparator

Intervention: Nitrous oxide (Drug)

20% nitrous oxide

Active Comparator

Intervention: Nitrous oxide (Drug)

0% Nitrous oxide

Placebo Comparator

Intervention: Nitrous oxide (Drug)

10% nitrous oxide

Active Comparator

Intervention: Nitrous oxide (Drug)

40% nitrous oxide

Active Comparator

Intervention: Nitrous oxide (Drug)

Outcomes

Primary Outcomes

Pain intensity, pain bothersomeness

Time Frame: 25, 70, & 115 min of inhalation and 40 min post

Subjects will inhale varying conc of nitrous oxide for 120 min with cold immersion of forearm at 25, 70, and 115 min and 40 min after inhalation. Pain intensity and bothersomeness will be assessed at each immersion.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials